Real-time enrollment status for this blood clots clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT06299111 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Blood Clots |
| Phase | Clinical Trial |
| Target Enrollment | 195 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | January 12, 2026 (Jan 12, 2026) |
As of March 2, 2026: Clinical trial NCT06299111 is currently active_not_recruiting participants. This clinical trial study for blood clots is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06299111 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06299111 was last updated Jan 12, 2026 (January 12, 2026). HelloStudys verifies this status automatically.